CYDEX PHARMACEUTICALS
CyDex Pharmaceuticals, Inc., a pharmaceutical company, engages in the development and commercialization of drugs specifically designed to address limitations of current therapies. It develops a portfolio of product candidates utilizing its drug formulation technology using Captisol, a group of cyclodextrins. The company's products include Geodon IM and Abilify Injection IM for bipolar disorder/schizophrenia; Vfend IV for antifungal; and Cerenia for canine motion sickness. It also develops Fosphe... nytoin IV and IM for status epilepticus; Melphalan IV for multiple myeloma; Topiramate IV for epilepsy; Amiodarone IV for arrhythmia; Budesonide Solution Inhalation for asthma; Clopidogrel IV for atherothrombosis; and Budesonide/Azelastine Nasal Spray for allergic rhinitis. In addition, the company out license its technology to third parties for use in the development of their products. CyDex Pharmaceuticals, Inc. was formerly known as CyDex, Inc. and it changed its name in November 2007. The company was founded in 1993 and is based in Lenexa, Kansas.
CYDEX PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Developer Platform Pharmaceutical
Founded:
1993-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.captisol.com
Total Employee:
11+
Status:
Active
Contact:
877-575-5593
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Apache Microsoft Exchange Online Amazon
Similar Organizations
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Newest Events participated
Participated in 7th American Drug Delivery and Formulation Summit 2017
on 2017-08-28 as sponsor
Official Site Inspections
http://www.captisol.com Semrush global rank: 7.88 M Semrush visits lastest month: 417
- Host name: ec2-174-129-30-187.compute-1.amazonaws.com
- IP address: 174.129.30.187
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "CyDex Pharmaceuticals"
About - Captisol
Captisol® is a patented cyclodextrin for use in drug development and formulation. FDA-approved, Captisol-enabled® medications are marketed by partners including Amgen, Pfizer, Merck & …See details»
Captisol
Captisol® can be used for oral, ophthalmic, nasal, inhalation, and parenteral administration. By significantly improving the solubility, stability, and therefore bioavailability of insoluble …See details»
Ligand Pharmaceuticals - Biopharma's Technology and Capital …
We also maintain and license our Captisol® technology platform with broad applicability in drug development to a large network of biopharmaceutical partners, including the largest …See details»
History - Captisol
Heritage. Now Ligand-owned, Captisol ® was invented and initially developed by scientists at the University of Kansas' Higuchi Biosciences Center for specific use in drug development and …See details»
CyDex Pharmaceuticals - Crunchbase Company Profile & Funding
Jan 27, 2011 CyDex Pharmaceuticals, Inc., a pharmaceutical company, engages in the development and commercialization of drugs specifically designed to address limitations of …See details»
Ligand Pharmaceuticals Corporate Profile - American …
The Captisol® technology is used to address the limitations of currently marketed drugs. Eight FDA-approved, Captisol-enabled® medications are marketed by: Pfizer, Bristol-Myers Squibb …See details»
WHAT IS CAPTISOL WH - d1io3yog0oux5.cloudfront.net
CAPTISOL ® can also enhance the oral bioavailability of poorly water soluble compounds if solubility and dissolution are the contributing limiting factors. R=(H) 21-n or (CH 2 CH 2 CH 2 …See details»
Hovione Announces Partnership to Produce Ligand’s Captisol; …
Sep 24, 2020 “To meet Captisol demand associated with Veklury, Hovione will soon be producing per month the quantity it usually produces in 1 year. ... Hovione is an international …See details»
Parenteral Formulation Development With Captisol® - Singota …
Jun 13, 2023 Captisol is a patent protected, uniquely modified cyclodextrin, with a chemical structure that was designed to enable the creation of new products by significantly improving …See details»
Partnerships - Captisol
Captisol® offers a wide-range of in-depth industry expertise and enables formulation solutions for a variety of products. In addition, Ligand has strong Captisol®-related alliances with partners …See details»
WHAT IS CAPTISOL - CPHI Online
CAPTISOL ® stabilizes some protein and peptide formula-tions by minimizing aggregation, preventing adsorption to containers and aiding in refolding. The presence of CAPTISOL ® has …See details»
Captisol : What gives European Pharmacopeia?! - Singota Solutions
Jun 5, 2017 Captisol® Compendial Testing: EP Complexities USP (United States Pharmacopeia) – NF (National Formulary) monograph for Captisol (Betadex Sulfobutylether …See details»
Captisol - Pharma Excipients
Captisol® formulations are biocompatible and can be administered parenterally, orally, ophthalmically, nasally, topically and via inhalation. Product Advantage. Product development …See details»
Captisol® Modified Cyclodextrin from Ligand Pharmaceuticals
Captisol® is a patent protected, uniquely modified cyclodextrin, whose chemical structure was rationally designed to enable the creation of new products by significantly improving solubility, …See details»
SOLUBILIZING & STABILIZING TECHNOLOGY - CAPTISOL® - Part …
INTRODUCTION . While Captisol (Betadex Sulfobutylether Sodium) is a remarkable narrative of a successfully functional excipient broadly accepted as the premier solubilizing and stabilizing …See details»
Captisol®: an efficient carrier and solubilizing agent for essential ...
Jun 5, 2017 Captisol® and HP-β-CD showed better complexation ability than Captisol-G® and γ-CD towards all ten guests reflected by higher K f values. This is due to the fact that the …See details»
Captisol Successes
Captisol is currently in 15 FDA-approved products and additional approvals are expected in the next 24 months. These products span many types of molecules (neutral, charged, MW [236 …See details»
How it Works - Captisol
Captisol® formulations are biocompatible and can be administered parenterally, orally, ophthalmically, nasally, topically and via inhalation. Captisol® is Safe. Captisol® was designed …See details»
Captisol®: an efficient carrier and solubilizing agent for essential ...
Both Captisol® and HP‐β‐CD greatly increased the apparent solubility of EOs. The solubilizing potential was inversely proportionate to the EOs intrinsic solubility (S EO). Results indicated …See details»
Benefits - Captisol
Product Advantages. Product development is a complex process from discovery and evaluation through development and commercialization. Captisol ® provides a useful and elegant …See details»